“…Subjects were admitted to the study unit the evening prior to dosing on day 1 through the morning of day 2, from the morning of day 8 through the morning of day 9, and from the morning of day 18 through the last blood draw on day 20. Subjects visited the study unit on days 3, 4, 7, 10, 11,12,13,14,15,16, and 17 for pharmacokinetic and safety evaluations.…”